Japan has officially launched a public comment period for its landmark cannabis reform bill, offering new details on how its nascent cannabis industry will look over the coming months.
On May 30, the Japanese government announced that it would now be accepting public comments from interested parties on five measures of the new bill.
Most notably, the preliminary proposals suggest that Japan is seeking to forgo the complex and lengthy Novel Foods process for CBD products, and could become the first country to approve CBD in food.
Yves Antoniazzi, Managing Director of Astrasana Holding AG, one of the few international companies to have a foothold in the Japanese CBD market, said: “We have been waiting a long time for this. It is a huge milestone for the global cannabis industry. Japan is the one of the first countries to approve CBD in food, paving the way for corporate companies to list CBD products in retail chains.”
Business of Cannabis will be digging deeper into the details of Japan’s new proposals and providing analysis into their implications for businesses in the coming days.
What happened?
Late last year, Japan made a major step towards cannabis reform after approving a bill to amend its 75-year-old Cannabis Control Act.
After passing the bill in November, the Japanese authorities have been ironing out the details of these reforms, and the industry has been poised for an announcement from the Ministry of Health, Labour and Welfare (MHLW) laying out the new framework.
The public comment period, which will last until June 13 or 29, offers medical professionals and CBD businesses the opportunity to examine the draft order and voice their concerns before a final decision is made and the amendments can be enacted.
Opinions are now being solicited on five topics, including law enforcement, THC analysis methods, the development of related laws and regulations, and first and second-class cultivation license reviews.
As previously reported, the bill is set to amend a few key measures which could enable the country’s CBD and medical cannabis industries to flourish.
Primarily, while Japan already has a booming CBD industry, it currently only allows products with no trace THC. This is expected to change, and initial reports suggest this could rise to 0.3%.
‘Huge Milestone’ as Japan Moves Ahead With Cannabis Reform
Japan has officially launched a public comment period for its landmark cannabis reform bill, offering new details on how its nascent cannabis industry will look over the coming months.
On May 30, the Japanese government announced that it would now be accepting public comments from interested parties on five measures of the new bill.
Most notably, the preliminary proposals suggest that Japan is seeking to forgo the complex and lengthy Novel Foods process for CBD products, and could become the first country to approve CBD in food.
Yves Antoniazzi, Managing Director of Astrasana Holding AG, one of the few international companies to have a foothold in the Japanese CBD market, said: “We have been waiting a long time for this. It is a huge milestone for the global cannabis industry. Japan is the one of the first countries to approve CBD in food, paving the way for corporate companies to list CBD products in retail chains.”
Business of Cannabis will be digging deeper into the details of Japan’s new proposals and providing analysis into their implications for businesses in the coming days.
What happened?
Late last year, Japan made a major step towards cannabis reform after approving a bill to amend its 75-year-old Cannabis Control Act.
After passing the bill in November, the Japanese authorities have been ironing out the details of these reforms, and the industry has been poised for an announcement from the Ministry of Health, Labour and Welfare (MHLW) laying out the new framework.
The public comment period, which will last until June 13 or 29, offers medical professionals and CBD businesses the opportunity to examine the draft order and voice their concerns before a final decision is made and the amendments can be enacted.
Opinions are now being solicited on five topics, including law enforcement, THC analysis methods, the development of related laws and regulations, and first and second-class cultivation license reviews.
As previously reported, the bill is set to amend a few key measures which could enable the country’s CBD and medical cannabis industries to flourish.
Primarily, while Japan already has a booming CBD industry, it currently only allows products with no trace THC. This is expected to change, and initial reports suggest this could rise to 0.3%.
Organigram Signs 2nd UK Supply Deal With Avida Medical
Next PostCanopy Growth Trims Losses Significantly as It Prepares for Financial Boost From Rescheduling
Ben Stevens
Editor and Journalist with more than seven years experience reporting on business and financial sectors.
Related Posts
Related Posts
Mamedica CEO Predicts Rapid Growth for UK Medical Cannabis Market, But Infrastructure Needs to Catch Up
Last month, one of the first cannabis entrants onto the London Stock Exchange, Oxford Cannabinoid Technologies, announced plans to depart...
Former DEA Leaders and GOP AGs Demand Public Hearing on Cannabis Rescheduling
Former Drug Enforcement Agency (DEA) leaders and Republican state attorney generals have called for a public hearing on plans to...
Cannaray, Therismos, and Aqualitas Unite to Launch Wellford at Cannabis Europa
Althea Reveal New Leadership Team Following Global Reorganisation
Prohibition Partners Launches New Bespoke Data & Analysis Packages
Anti-Cannabis Group Calls on DOJ to Extend Rescheduling Comment Period to Collect More Data
CONNECT
Related Posts
Related Posts
Mamedica CEO Predicts Rapid Growth for UK Medical Cannabis Market, But Infrastructure Needs to Catch Up
Last month, one of the first cannabis entrants onto the London Stock Exchange, Oxford Cannabinoid Technologies, announced plans to depart...
Former DEA Leaders and GOP AGs Demand Public Hearing on Cannabis Rescheduling
Former Drug Enforcement Agency (DEA) leaders and Republican state attorney generals have called for a public hearing on plans to...
Cannaray, Therismos, and Aqualitas Unite to Launch Wellford at Cannabis Europa
Cannaray Limited, its medical cannabis subsidiary Therismos, and Canadian ‘aquaponics’ cannabis cultivator Aqualitas are set to merge to create a...
Althea Reveal New Leadership Team Following Global Reorganisation
Althea Group Holdings Limited (ASX:AGH) (‘AGH’), today announced their new senior leadership team following the successful completion of company restructuring....
Prohibition Partners Launches New Bespoke Data & Analysis Packages
Prohibition Partners, leading providers of data, intelligence and insights on international cannabis markets, are announcing the launch of their new...
Recent Posts
Related Posts
Chill Brands Ousted Directors Transferred $400k to Personal Accounts While CEO Absent, & Germany’s CanG Changes Boost Cannovum’s Stock
Chill Brands Chill Brands’ ongoing boardroom debacle took another dramatic turn this week following revelations that its ousted directors...
Italy’s Hemp Sector Fights Back Against Government Ban, Seeks EU Intervention
Italy’s hemp industry has called on the European Commission (EC) to intervene after the government moved to ban the cultivation,...
Japan Publishes Details of Newly Proposed THC Limits For Incoming Cannabis Market
Last week, Japan officially launched a public comment period for draft legislation set to regulate the country’s emerging cannabis and...
‘Hemp Killing’ Amendment Which Would Make 95% of Hemp Products Illegal Added to Farm Bill, But ‘War is Far From Over’
An amendment described as ‘devastating’ for the US’ hemp and CBD industries has now been passed and will be part...
Czech Republic’s Revolutionary Legislation to Regulate Psychoactive Substances Such as HHC Clears First Hurdle
The Czech Republic’s lower house has passed a proposal seeking to regulate ‘psychomodulating’ substances, which is likely to include synthetic...
Subscribe to our mailing list to receives daily updates!
We won’t spam you
Categories
Browse by Tags